Centre Hospitalier Regional Et Universitaire De Lille (chru);Universite Du Littoral Cote Dopale;Universite Du Littoral Cote D'opale;Universite de Lille 2 Droit et Sante
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.